Stevanato Group (STVN)
Develops pharmaceutical containment, delivery, diagnostic, and manufacturing solutions for drug-development and production workflows.
$20.95
vs last close−0.75 (−3.46%)
In millions of USD, except per-share figures · converted from EUR at the latest rate
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 309 | 365 | 269 | 295 | 316 | 376 | 292 | 319 | 345 | 391 | 311 | 344 |
| Cost of revenue | 215 | 249 | 198 | 219 | 232 | 265 | 213 | 229 | 244 | 270 | 226 | 245 |
| Gross profit | 94 | 116 | 71 | 77 | 85 | 112 | 80 | 89 | 101 | 121 | 86 | 99 |
| 36 | 43 | 42 | 45 | 38 | 36 | 40 | 42 | 41 | 45 | 41 | 54 | |
| Research & development | 10 | 11 | 12 | 10 | 8 | 6 | 7 | 7 | 9 | 7 | 7 | 7 |
| 29 | 35 | 31 | 34 | 32 | 36 | 35 | 37 | 35 | 39 | 34 | 36 | |
| Selling & marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7 | 9 |
| General & administrative | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 27 | 27 |
| Other expenses | −3 | −3 | −1 | 1 | −1 | −6 | −1 | −1 | −3 | 0 | 1 | 11 |
| Operating income | 58 | 73 | 29 | 32 | 47 | 76 | 39 | 47 | 60 | 75 | 44 | 45 |
| −1 | −6 | 0 | 1 | 0 | −3 | 1 | −3 | −4 | −1 | 1 | −1 | |
| Interest income | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Interest expense | 1 | 2 | 2 | 1 | 2 | 3 | 2 | 2 | 2 | 5 | 1 | 2 |
| Other non-operating income | 0 | 4 | −1 | −2 | −2 | −1 | −2 | 1 | 2 | −4 | −2 | −1 |
| Income before tax | 57 | 67 | 29 | 33 | 46 | 74 | 40 | 45 | 56 | 74 | 45 | 43 |
| Income tax expense | 14 | 15 | 8 | 10 | 12 | 19 | 10 | 11 | 15 | 21 | 13 | 17 |
| Net income from continuing operations | 43 | 51 | 21 | 23 | 34 | 55 | 30 | 34 | 41 | 54 | 32 | 26 |
| Net income | 43 | 51 | 21 | 23 | 34 | 55 | 30 | 34 | 41 | 54 | 32 | 26 |
| EPS, basic | $0.17 | $0.19 | $0.08 | $0.09 | $0.13 | $0.20 | $0.11 | $0.13 | $0.15 | $0.19 | $0.11 | $0.09 |
| EPS, diluted | $0.17 | $0.19 | $0.08 | $0.09 | $0.13 | $0.20 | $0.11 | $0.13 | $0.15 | $0.19 | $0.11 | $0.09 |
| Weighted average shares, basic | 271 | 266 | 266 | 273 | 273 | 273 | 273 | 273 | 273 | 273 | 273 | 273 |
| Weighted average shares, diluted | 265 | 266 | 266 | 273 | 273 | 273 | 273 | 273 | 273 | 273 | 273 | 273 |
| EBITDA | 82 | 91 | 55 | 58 | 118 | 99 | 65 | 71 | 83 | 107 | 74 | 46 |
| Depreciation & amortization | 23 | 23 | 25 | 24 | 69 | 22 | 23 | 25 | 25 | 28 | 28 | 0 |
| EBIT | 59 | 69 | 30 | 34 | 48 | 77 | 42 | 46 | 58 | 79 | 46 | 46 |